Epilepsy Monitoring Device Market Overview

The global Epilepsy Monitoring Device Market is expected to grow at a moderate rate during the forecast period. Rising case of epilepsy globally is one the major factor driving the growth of market. The estimates provided by WHO states that the proportion of people with active epilepsy at a given time is between 4 to 10 per 1000 people. The proportion is less in high-income countries, which is estimated to be 48 per 100 000 people diagnosed with epilepsy each year.
 
Moreover, growth in awareness about epilepsy and increased use of monitoring devices is likely to have a positive impact on the market growth over the forecast period..
 
However, diagnostic challenge can be a major factor that hinders the growth of this market. Upon referral to epilepsy centres, up to 40 percent of patients with a diagnosis of refractory epilepsy are found to have been misdiagnosed.
 
Covid-19 Impact on Epilepsy Monitoring Device Market:
 
In addition, the current Epilepsy Monitoring Device Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Epilepsy Monitoring Device Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
 
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
 
Epilepsy Monitoring Device Market Segment Overview

Depending on the product, the global epilepsy monitoring device market is classified into conventional devices and wearable devices. Among these, the conventional devices segment is expected to witness high growth during the forecast period owing to the increased application of these systems in hospitals and diagnostics centers.
 
Based on end-user, the global epilepsy monitoring device market is classified into clinics, hospitals, home care settings, and other end users. Among these, the hospital's segment is expected to witness high growth during the forecast period owing to the increasing number of patients suffering from neurological disorders.
 
Market Analysis, Insights and Forecast – By Product
·       Conventional Devices
·       Wearable Devices

Market Analysis, Insights, and Forecast – By End User
·       Clinics
·       Hospitals
·       Home Care Settings
·       Other End Users
 
Epilepsy Monitoring Device Market Regional Overview

The global Epilepsy Monitoring Device market is segmented into North America, Europe, Asia-Pacific, and LAMEA. By region, North America accounted for largest market share in 2020, in the global Epilepsy Monitoring Device market. The growing prevalence of epilepsy, increasing number of product approvals and launches in the region, and large presence of device manufacturing companies has contributed to the largest revenue shares in the region.As per the data from the Centres for Disease Control and Prevention (CDC), more Americans have epilepsy than ever before. Overall, 1.2 percent of the U.S. population (3.4 million people) reported active epilepsy in 2015. On the other hand, Asia Pacific is expected to grow with the highest CAGR over the forecast period. The growth is atrributed due to the growing opportunity and rapid developing healthcare infrastructure in countries such as India and China.

Epilepsy Monitoring Device Market, By Geography
 
·       North America (US & Canada)
·       Europe (UK, Germany, France, Italy, Spain, & Rest of Europe)
·       Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
·       LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
 
Epilepsy Monitoring Device Market Competitor overview

Some key developments and strategies adopted by manufacturers in the Epilepsy Monitoring Device  are highlighted below.
 
·       In October 2019, Medtronic plc has launched its advanced Patient Programmer technology for Deep Brain Stimulation (DBS) therapy.

Epilepsy Monitoring Device Market, Key Players

·       Natus Medical Incorporated
·       Nihon Kohden Corporation
·       PulseGuard International Ltd.
·       Medtronic Plc
·       Koninklijke Philips N.V.
·       LivaNova, PLC
·       St. Jude Medical, Inc.
·       Empatica Inc.
·       Boston Scientific Corporation